세계의 연구용 항체 및 시약 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

The global demand for Research Antibodies & Reagents Market is presumed to reach the market size of nearly USD 22.66 Billion by 2032 from USD 11.97 Billion in 2023 with a CAGR of 7.35% under the study period 2024 - 2032.

Research antibodies & reagents are essential tools in the scientific study of biological processes, diseases, and cellular mechanisms. Antibodies specifically designed to bind to unique antigens allow researchers to detect and quantify specific proteins or molecules within complex biological samples. Reagents, including buffers, stains, and other chemical compounds, facilitate various experimental techniques such as immunohistochemistry, ELISA, and Western blotting. Together, these products enable detailed investigation and analysis in biomedical research, contributing to advancing knowledge and developing new therapeutic strategies.

MARKET DYNAMICS

The rise in demand for high-quality antibodies for research reproducibility is one of the major factors driving the growth of the research antibodies and reagents market. Moreover, rising investment in medical and health R&D is expected to fuel growth in the research antibodies and reagents market. The growing applications of biosciences and biotechnology in healthcare and pharmaceutical fields are driving demand. Furthermore, increased investment in the life sciences industry is driving up the need for research antibodies and reagents. Additionally, the increase in industry-academia collaboration and rising stem cell and neurobiology research field further influences the research antibodies and reagents market. However, the high cost and time related to identifying and developing potential antibodies are expected to hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Research Antibodies & Reagents. The growth and trends of Research Antibodies & Reagents industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Research Antibodies & Reagents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Reagent (Media & Sera, Stains & Dyes, Fixatives, Buffers, Solvents, Enzymes, Probes, Other Reagents)
• Antibodies

By Type

• Primary Antibodies
• Secondary Antibodies

By Form

• Monoclonal
• Polyclonal
• Recombinant

By Source

• Mice
• Rabbits
• Other Sources

By Research Area

• Oncology
• Infectious Diseases
• Immunology
• Neurobiology
• Stem Cells
• Other Research Areas

By Technology

• Western Blotting
• Flow Cytometry
• Enzyme-Linked Immunosorbent Assay (Elisa)
• Immunohistochemistry
• Immunofluorescence
• Immunoprecipitation
• Other Technologies

By Application

• Proteomics
• Drug Development
• Genomics

By End User

• Pharmaceutical & Biotechnologies Industries
• Academic & Research Institutions
• Contract Research Organizations

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Research Antibodies & Reagents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Research Antibodies & Reagents market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Abcam Plc (UK), Becton, Dickinson, Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), BioLegend (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . RESEARCH ANTIBODIES & REAGENTS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Type
  • 3.7.3 Market Attractiveness Analysis By Form
  • 3.7.4 Market Attractiveness Analysis By Source
  • 3.7.5 Market Attractiveness Analysis By Research Area
  • 3.7.6 Market Attractiveness Analysis By Technology
  • 3.7.7 Market Attractiveness Analysis By Application
  • 3.7.8 Market Attractiveness Analysis By End User
  • 3.7.9 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SALES BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Sales Data
• 5.3 Analysis by Product
• 5.4 Reagent (Media & Sera, Stains & Dyes, Fixatives, Buffers, Solvents, Enzymes, Probes, Other Reagents) Historic and Forecast Sales by Regions
• 5.5 Antibodies Historic and Forecast Sales by Regions

6 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY TYPE

• 6.1 Overview by Type
• 6.2 Historical and Forecast Sales Data
• 6.3 Analysis by Type
• 6.4 Primary Antibodies Historic and Forecast Sales by Regions
• 6.5 Secondary Antibodies Historic and Forecast Sales by Regions

7 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY FORM

• 7.1 Overview by Form
• 7.2 Historical and Forecast Sales Data
• 7.3 Analysis by Form
• 7.4 Monoclonal Historic and Forecast Sales by Regions
• 7.5 Polyclonal Historic and Forecast Sales by Regions
• 7.6 Recombinant Historic and Forecast Sales by Regions

8 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY SOURCE

• 8.1 Overview by Source
• 8.2 Historical and Forecast Sales Data
• 8.3 Analysis by Source
• 8.4 Mice Historic and Forecast Sales by Regions
• 8.5 Rabbits Historic and Forecast Sales by Regions
• 8.6 Other Sources Historic and Forecast Sales by Regions

9 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY RESEARCH AREA

• 9.1 Overview by Research Area
• 9.2 Historical and Forecast Sales Data
• 9.3 Analysis by Research Area
• 9.4 Oncology Historic and Forecast Sales by Regions
• 9.5 Infectious Diseases Historic and Forecast Sales by Regions
• 9.6 Immunology Historic and Forecast Sales by Regions
• 9.7 Neurobiology Historic and Forecast Sales by Regions
• 9.8 Stem Cells Historic and Forecast Sales by Regions
• 9.9 Other Research Areas Historic and Forecast Sales by Regions

10 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY TECHNOLOGY

• 10.1 Overview by Technology
• 10.2 Historical and Forecast Sales Data
• 10.3 Analysis by Technology
• 10.4 Western Blotting Historic and Forecast Sales by Regions
• 10.5 Flow Cytometry Historic and Forecast Sales by Regions
• 10.6 Enzyme-Linked Immunosorbent Assay (Elisa) Historic and Forecast Sales by Regions
• 10.7 Immunohistochemistry Historic and Forecast Sales by Regions
• 10.8 Immunofluorescence Historic and Forecast Sales by Regions
• 10.9 Immunoprecipitation Historic and Forecast Sales by Regions
• 10.1 Other Technologies Historic and Forecast Sales by Regions

11 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY APPLICATION

• 11.1 Overview by Application
• 11.2 Historical and Forecast Sales Data
• 11.3 Analysis by Application
• 11.4 Proteomics Historic and Forecast Sales by Regions
• 11.5 Drug Development Historic and Forecast Sales by Regions
• 11.6 Genomics Historic and Forecast Sales by Regions

12 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY DRUG DEVELOPMENT

• 12.1 Overview by End User
• 12.2 Historical and Forecast Sales Data
• 12.3 Analysis by End User
• 12.4 Pharmaceutical & Biotechnologies Industries Historic and Forecast Sales by Regions
• 12.5 Academic & Research Institutions Historic and Forecast Sales by Regions
• 12.6 Contract Research Organizations Historic and Forecast Sales by Regions

13 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY GEOGRAPHY

• 13.1. Regional Outlook
• 13.2. Introduction
• 13.3. North America Sales Analysis
  • 13.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 13.3.2. North America By Segment Sales Analysis
  • 13.3.3. North America By Country Sales Analysis
  • 13.3.4. United State Sales Analysis
  • 13.3.5. Canada Sales Analysis
  • 13.3.6. Mexico Sales Analysis
• 13.4. Europe Sales Analysis
  • 13.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 13.4.2. Europe by Segment Sales Analysis
  • 13.4.3. Europe by Country Sales Analysis
  • 13.4.4. United Kingdom Sales Analysis
  • 13.4.5. France Sales Analysis
  • 13.4.6. Germany Sales Analysis
  • 13.4.7. Italy Sales Analysis
  • 13.4.8. Russia Sales Analysis
  • 13.4.9. Rest Of Europe Sales Analysis
• 13.5. Asia Pacific Sales Analysis
  • 13.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 13.5.2. Asia Pacific by Segment Sales Analysis
  • 13.5.3. Asia Pacific by Country Sales Analysis
  • 13.5.4. China Sales Analysis
  • 13.5.5. India Sales Analysis
  • 13.5.6. Japan Sales Analysis
  • 13.5.7. South Korea Sales Analysis
  • 13.5.8. Australia Sales Analysis
  • 13.5.9. South East Asia Sales Analysis
  • 13.5.10. Rest Of Asia Pacific Sales Analysis
• 13.6. Latin America Sales Analysis
  • 13.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 13.6.2. Latin America by Segment Sales Analysis
  • 13.6.3. Latin America by Country Sales Analysis
  • 13.6.4. Brazil Sales Analysis
  • 13.6.5. Argentina Sales Analysis
  • 13.6.6. Peru Sales Analysis
  • 13.6.7. Chile Sales Analysis
  • 13.6.8. Rest of Latin America Sales Analysis
• 13.7. Middle East & Africa Sales Analysis
  • 13.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 13.7.2. Middle East & Africa by Segment Sales Analysis
  • 13.7.3. Middle East & Africa by Country Sales Analysis
  • 13.7.4. Saudi Arabia Sales Analysis
  • 13.7.5. UAE Sales Analysis
  • 13.7.6. Israel Sales Analysis
  • 13.7.7. South Africa Sales Analysis
  • 13.7.8. Rest Of Middle East And Africa Sales Analysis

14 . COMPETITIVE LANDSCAPE OF THE RESEARCH ANTIBODIES & REAGENTS COMPANIES

• 14.1. Research Antibodies & Reagents Market Competition
• 14.2. Partnership/Collaboration/Agreement
• 14.3. Merger And Acquisitions
• 14.4. New Product Launch
• 14.5. Other Developments

15 . COMPANY PROFILES OF RESEARCH ANTIBODIES & REAGENTS INDUSTRY

• 15.1. Company Share Analysis
• 15.2. Market Concentration Rate
• 15.3. Thermo Fisher Scientific Inc. (US)
  • 15.3.1. Company Overview
  • 15.3.2. Company Revenue
  • 15.3.3. Products
  • 15.3.4. Recent Developments
• 15.4. Merck KGaA (Germany)
  • 15.4.1. Company Overview
  • 15.4.2. Company Revenue
  • 15.4.3. Products
  • 15.4.4. Recent Developments
• 15.5. Abcam Plc (UK)
  • 15.5.1. Company Overview
  • 15.5.2. Company Revenue
  • 15.5.3. Products
  • 15.5.4. Recent Developments
• 15.6. Becton, Dickinson Company (US)
  • 15.6.1. Company Overview
  • 15.6.2. Company Revenue
  • 15.6.3. Products
  • 15.6.4. Recent Developments
• 15.7. BioLegend (US)
  • 15.7.1. Company Overview
  • 15.7.2. Company Revenue
  • 15.7.3. Products
  • 15.7.4. Recent Developments
• 15.8. GenScript (China)
  • 15.8.1. Company Overview
  • 15.8.2. Company Revenue
  • 15.8.3. Products
  • 15.8.4. Recent Developments
• 15.9. Bio-Rad Laboratories (US)
  • 15.9.1. Company Overview
  • 15.9.2. Company Revenue
  • 15.9.3. Products
  • 15.9.4. Recent Developments
• 15.10. Cell Signaling Technology (US)
  • 15.10.1. Company Overview
  • 15.10.2. Company Revenue
  • 15.10.3. Products
  • 15.10.4. Recent Developments
• 15.11. F. Hoffmann-La Roche (Switzerland)
  • 15.11.1. Company Overview
  • 15.11.2. Company Revenue
  • 15.11.3. Products
  • 15.11.4. Recent Developments
• 15.12. Danaher Corporation (US)
  • 15.12.1. Company Overview
  • 15.12.2. Company Revenue
  • 15.12.3. Products
  • 15.12.4. Recent Developments
• 15.13. Agilent Technologies (US)
  • 15.13.1. Company Overview
  • 15.13.2. Company Revenue
  • 15.13.3. Products
  • 15.13.4. Recent Developments
• 15.13. PerkinElmer (US)
  • 15.13.1. Company Overview
  • 15.13.2. Company Revenue
  • 15.13.3. Products
  • 15.13.4. Recent Developments
• 15.15. Lonza (Switzerland)
  • 15.15.1. Company Overview
  • 15.15.2. Company Revenue
  • 15.15.3. Products
  • 15.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies